Month: January 2023

Louvain-La-Neuve, Belgium, 10 January 2023 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces that it has received the downpayment for a contract signed at the end of December 2022 with the H. Lee Moffitt Cancer Center and Research Institute Hospital (“Moffitt”) in Tampa, Florida, US, for the installation of its Proteus®ONE1 compact proton therapy system. As Florida’s only National Cancer Institute-designated comprehensive cancer center, Moffitt previously announced this new proton therapy treatment facility as part of its ongoing expansion. IBA’s Proteus®ONE, as the only user-centric compact Imaged Guided Intensity Modulated Proton Therapy solution, includes Cone Beam Computed Tomography (CBCT) and an open gantry solution with surface-guided proton therapy capabilities...

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, January 10, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces that through a share exchange it will receive the equivalent of CHF 5 million Idorsia shares which Santhera is free to sell at its own discretion in support of its short-term financial needs. Upon completion of the transaction Idorsia will hold 17.7% of Santhera’s registered share capital. Under the terms of this transaction, Idorsia Pharmaceuticals Ltd will receive 5,529,016 Santhera shares valued at CHF 0.9043 per share which corresponds to the five-day volume weighted average price (VWAP) ending January 9, 2023, minus a twenty percent discount. In addition, Idorsia will receive 2,211,607 warrants (or 0.4 warrant per Santhera share received), each of which is exercisable for one Santhera share at an exercise...

LA JOLLA, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Allowance from the Brazilian Patent and Trademark Office for a pending patent application which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for the treatment of hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia. Once issued, the patent maturing from this allowed patent application is expected to expire no earlier than July 2034. The allowed claims cover the use of MN-001 or MN-002 for reducing a triglyceride blood level, for reducing a total cholesterol blood level, and for reducing a low density lipoprotein (LDL) blood level. The...

Perth, Jan. 10, 2023 (GLOBE NEWSWIRE) — QUARTERLY REPORT INVESTOR WEBINAR / CALL Perth, Western Australia/January 10, 2023/ Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss its December 2022 Quarterly Results, which are anticipated for release around 8:30am AEDT on Tuesday January 24, 2023. CALL DETAILSAustralia: Tuesday 24 January 2023 Perth – 6:00am Sydney/Melbourne – 9:00am Canada: Monday 23 January 2023 Vancouver – 2:00pm Toronto – 5:00pm UK: Monday 23 January 2023 London – 10:00pmRegister for the investor webinar at the link below: https://us02web.zoom.us/webinar/register/WN_85uUKlsQRDaSiT7UPtFziw After registering, you will receive a confirmation email containing information about joining the webinar. To join the webinar via telephone, please use one of the following...

LONDON and AMSTERDAM, Jan. 09, 2023 (GLOBE NEWSWIRE) — Blockmate Ventures Inc. (the “Company”) (TSX.V: MATE) (FSE: 8MH1) is pleased to announce that it has completed a final tranche of its non-brokered private placement (the “Offering”) for additional gross proceeds of CAD $88,600. When combined with the initial tranche of the Offering completed on November 17, 2022, the Company has raised $903,267. In connection with completion of the final tranche of the Offering, the Company has issued 1,772,000 units (each, a “Unit”) at a price of $0.05 per Unit. Each “Unit” consists of one common share, and one common share purchase warrant exercisable to acquire a further common share at a price of $0.075 until January 6, 2026. All securities issued in connection with the Offering are subject to restrictions on resale until May 7, 2023 in...

Analyst Conference Call – 8:00 a.m. Pacific, Friday, February 10, 2023 BURNABY, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) will release its fourth quarter and fiscal 2022 financial results on February 9, 2023. Information related to Interfor’s fourth quarter and fiscal 2022 financial results will be available at www.interfor.com/investors. The analyst conference call is scheduled for 8:00 a.m. Pacific on Friday, February 10, 2023. It will feature a brief summary of financial results by Interfor management followed by a question and answer period with analysts. The dial-in phone number is: 1-888-396-8049 The conference call will also be recorded for those unable to join the live discussion. The number to call to listen to the recording is 1-877-674-7070, Passcode...

Settlement Explicitly Does Not Constitute Admission of Liability CLEVELAND, Jan. 09, 2023 (GLOBE NEWSWIRE) — Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced that its subsidiaries have reached agreements to settle the more than 870 ethylene oxide (“EO”) cases pending against Sterigenics in the Circuit Court of Cook County, Illinois, and US District Court for the Northern District of Illinois. Under the terms of the agreements, Sterigenics will pay $408 million to settle the claims, subject to substantially all of the plaintiffs providing opt-in consents to their individual settlement allocations and dismissing their claims with prejudice. The administration and completion of the...

TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres” or the “Trust”) (TSX: SRU.UN) announced today that it will issue its financial results for the three months and year ended December 31, 2022 on Wednesday, February 8, 2023. SmartCentres will hold a conference call on Thursday, February 9, 2023 at 3:00 p.m. (ET). Participating on the call will be members of SmartCentres’ senior management. Investors are invited to access the call by dialing 1-855-353-9183 and then keying in the participant passcode 14567#. A recording of this call will be made available Thursday, February 9, 2023, beginning at 8:30 p.m. (ET) through to 8:30 p.m. (ET) on Thursday, February 16, 2023. To access the recording, please call 1-855-201-2300, enter the conference access code 14567# and then key in the playback...

UNIONDALE, N.Y., Jan. 09, 2023 (GLOBE NEWSWIRE) — Flushing Financial Corporation (the “Company”) (Nasdaq-: FFIC), the parent holding company for Flushing Bank (the “Bank”), announced today that Michael J. Russo, a recently retired member of the Board of Directors has passed away. He was 88. Michael J. Russo retired from the Board of Directors on January 4, 2023 where he served as a Director on the Board of the Company and the Bank. He was a member of the Board of Directors of the Company since its formation in 1994 and of the Bank since 1984. Michael J. Russo was self-employed as a consulting engineer and served as Chief Executive Officer and Corporate Secretary of Fresh Meadow Mechanical Corp., a mechanical contracting firm. Mr. Russo was also President and Director of Operations of Northeastern Aviation Corp., an aircraft charter...